Staph. (coag. +) 20 0.125-0.5 Strep. (alpha hemol.) 10 0.5-8.0 Distribution in the Body: Enrofloxacin penetrates into all canine and feline tissues and body fluids. Concentrations of drug equal to or greater than the MIC for many pathogens (See Tables I, II and III) are reached in...
According to a previous report, iron-oxide in NP form is not only non-toxic, but its byproduct, degraded iron from the cores, apparently accumulates in natural iron stores in the body [113]. Properly biofunctionalized iron- oxide NPs have been shown to inhibit growth of Staph- ylococcus ...
solvothermal, pyrolysis and sonochemistry are used for the synthesis of CuO-NPs but these methods have several limitations such as long preparation time, consumption of large quantitities of reagents and
Antibacterial Activity (diameter in mm) Con- Mucor centra- (DL) Staph. Bac. Cand. mucedo tion Compound E. coli aureus subtilis albic. (*) ___ 0,1% C10 10.7 10.8 14.0 12.7 +- C12 19.1 16.9 18.0 17.3 ++ C14 10.6 10.3 10.9 13.4...
Staph. (coag. +) 20 0.125-0.5 Strep. (alpha hemol.) 10 0.5-8.0 Distribution in the Body: Enrofloxacin penetrates into all canine tissues and body fluids. Concentrations of drug equal to or greater than the MIC for many pathogens (See Tables I, II and III) are reached in most tissue...
Antibacterial Activity (diameter in mm) Concentration Compound E. coli Staph. aureus Bac. subtilis Cand. albic. Mucor mucedo( *) ___ 0.1% C10 10.0 10.2 13.0 12.1 +- C12 19.7 16.8 18.6 17.1 + C14 11.6 11.3 10.0 13.1 +- C16 10.0 10.0...